Advances in Wearable, Ingestible, and Implantable Devices for Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 October 2021) | Viewed by 361
Special Issue Editors
Interests: biopharmaceutics; controlled drug delivery; biomedical devices; biosensors; closed-loop therapies; nanomedicine
2. School of Medicine, University of North Carolina at Chapel Hill, Raleigh, NC 27599, USA
Interests: vascular disease; lymphatic vascular system; drug delivery devices; microcirculatory system
Special Issue Information
Dear Colleagues,
Engineered drug delivery devices, including transdermal patches, subcutaneous implants, intra-uterine devices, and wearable insulin pumps, have revolutionized patient care across diverse fields of medicine by providing patients with precise control over drug delivery, alternative routes of drug administration, and entirely new modes of pharmacotherapy. Clinical adoption of these systems has led to improvements in patients’ quality of life, adherence to therapy, and therapeutic outcome—often by redefining the patient experience. The next generation of drug delivery devices promises dramatically expanded device functionality, seamless and integrated patient-centric user experiences, and focused development to address unmet clinical opportunities.
This Special Issue aims to highlight recent advances and innovations in the area of wearable, ingestible and implantable drug delivery devices. Authors are invited to submit their original research or review articles within this subject area.
Dr. Jason Li
Prof. Dr. Michael Williams
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery devices
- transdermal and wearable devices
- implantable systems
- ingestible and gastro-retentive devices
- controlled drug delivery
- closed-loop drug delivery
- combination products
- biocompatible materials
- patient adherence
- adherence monitoring
